Oncology
Flowchart Overview
 
3
1
1
3
1
2
2
IIT-GEORGE-I-PREDICT Phase I/II OPEN TO ACCRUAL
NRG-BR008-HERO Phase III OPEN TO ACCRUAL
4
4
1
8
CARIBOU-CAMMOUFLAGE-CB-011A-MM Phase I OPEN TO ACCRUAL
CELGENE-GC-LTFU-001 Phase II/III OPEN TO ACCRUAL
GRACELL-GC012F-CD19-BCMA-001 Phase I/II OPEN TO ACCRUAL
GSK-3377794-LTFU Phase I OPEN TO ACCRUAL
IIT-SHAH-IL7-IL15-CD20-19 Phase I/II OPEN TO ACCRUAL
JNJ-MY4002-CARTINUE-LTFU Phase IV OPEN TO ACCRUAL
JUNO-017004-TRANSCEND-CLL Phase I/II OPEN TO ACCRUAL
SOTIO-BOXR1030 Phase I/II OPEN TO ACCRUAL
1
TRANSTHERA-TT420C2308 Phase III OPEN TO ACCRUAL
3
1
3
1
1
2
2
2
4
3
7
7
6
1
2
3
1
2
5
3
2
1
4
1
MAYO-ECHO-STUDY Phase II OPEN TO ACCRUAL
3
3
7
1
2
3
1
2
1
1
2
2
1
3
4
1
2
2
5
3
1
1
2
3
3
1
1
3
7
3
1
3
1
IIT-ABEDIN-PTCY-RUX-GVHD Phase II OPEN TO ACCRUAL
12
1
2
1
1
3
3
2
4
4
2
1
1
1
1
1
12
3
9
2
1
1
7
1
3
4
4
2
4
3
2
2
2
11
2
2
2
4
1
2
1
1
1
SOTIO-BOXR1030 Phase I/II OPEN TO ACCRUAL
1
2
2
5
1
1
SWOG-S2015 Phase III OPEN TO ACCRUAL
1
5
3
1
2
IIT-GORE-REDIRICT Phase II OPEN TO ACCRUAL
SOTIO-BOXR1030 Phase I/II OPEN TO ACCRUAL
2
3
1
1
1
3
9
7
1
1
2
CARNABIOSCIENCES-C1763102 Phase I OPEN TO ACCRUAL
IIT-GORE-REDIRICT Phase II OPEN TO ACCRUAL
12
11
3
2
2
1
1
1
4
3
3
3
1
3
3
1
3
3
1
3
3
1
3
3
1
2
2
1
1
6
3
3
1
1
1
1
2
1
1
2
1
2
3
8
4
6
5
5
4
10
1
6
1
IIT-GEORGE-I-PREDICT Phase I/II OPEN TO ACCRUAL
1
ALLIANCE-A151804 Phase N/A OPEN TO ACCRUAL